Albert Einstein College of Medicine

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1955-01-01

Employees: 1.9K

Market Cap: -

Website: http://einstein.yu.edu

Clinical Trials

HIPEC for Peritoneal Carcinomatosis

Phase 2

Completed

Conditions: Peritoneal Carcinomatosis
Colorectal Cancer
Appendiceal Cancer
Peritoneal Mesothelioma
Pseudomyxoma Peritonei
Gastric Cancer

Interventions: Procedure: HIPEC
Drug: Mitomycin C

First Posted Date: 2014-01-20

Last Posted Date: 2024-10-24

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 51

Registration Number: NCT02040142

Locations: 🇺🇸
Department of Surgery, Montefiore Medical Center- Weiler Division, Bronx, New York, United States

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

Phase 1

Terminated

Conditions: Adult Acute Myeloid Leukemia in Remission
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Interventions: Other: Laboratory Biomarker Analysis
Drug: Lenalidomide

First Posted Date: 2014-01-16

Last Posted Date: 2020-05-14

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 3

Registration Number: NCT02038153

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Montefiore Medical Center - Moses Campus, Bronx, New York, United States

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Phase 1

Completed

Conditions: Recurrent Non-Small Cell Lung Carcinoma
Stage IV Non-Small Cell Lung Cancer

Interventions: Drug: Azacitidine
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study

First Posted Date: 2013-12-12

Last Posted Date: 2020-02-07

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 8

Registration Number: NCT02009436

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring

Phase 1

Completed

Conditions: HIV

Interventions: Drug: TDF Intravaginal Ring
Drug: Placebo Intravaginal Ring

First Posted Date: 2013-12-10

Last Posted Date: 2018-08-28

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 30

Registration Number: NCT02006264

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Not Applicable

Terminated

Conditions: Stage IC Uterine Sarcoma
Stage IB Uterine Sarcoma
Stage IVA Uterine Sarcoma
Stage IA Uterine Sarcoma
Stage IIA Uterine Sarcoma
Stage IIIA Uterine Sarcoma
Stage IVB Uterine Sarcoma
Stage IIIB Uterine Sarcoma
Stage IIB Uterine Sarcoma
Stage IIIC Uterine Sarcoma

Interventions: Drug: Gemcitabine Hydrochloride
Drug: Docetaxel
Radiation: Internal Radiation Therapy
Radiation: Intensity-Modulated Radiation Therapy
Radiation: External Beam Radiation Therapy
Other: Laboratory Biomarker Analysis

First Posted Date: 2013-10-09

Last Posted Date: 2023-08-16

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 3

Registration Number: NCT01958580

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy

Not Applicable

Terminated

Conditions: Anxiety
Lung Neoplasm
Pain
Psychological Impact of Cancer
Digestive System Neoplasm
Depression
Post-Traumatic Stress Disorder

Interventions: Other: Questionnaire Administration
Other: Educational Intervention
Other: Meditation Therapy

First Posted Date: 2013-09-11

Last Posted Date: 2018-05-18

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 17

Registration Number: NCT01939210

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Not Applicable

Terminated

Conditions: DS (Durie/Salmon) Stage I Plasma Cell Myeloma
Refractory Plasma Cell Myeloma
DS Stage II Plasma Cell Myeloma
DS Stage III Plasma Cell Myeloma

Interventions: Drug: Desipramine Hydrochloride
Biological: Filgrastim
Other: Laboratory Biomarker Analysis

First Posted Date: 2013-07-15

Last Posted Date: 2023-03-28

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 10

Registration Number: NCT01899326

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Not Applicable

Completed

Conditions: Localized Non-Resectable Adult Liver Carcinoma
Recurrent Adult Liver Carcinoma
Adult Hepatocellular Carcinoma
Advanced Adult Hepatocellular Carcinoma

Interventions: Radiation: Stereotactic Radiosurgery

First Posted Date: 2013-07-15

Last Posted Date: 2022-11-29

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 20

Registration Number: NCT01899261

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Phase 2

Terminated

Conditions: Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer

Interventions: Drug: Fluorouracil
Drug: Gemcitabine Hydrochloride
Radiation: Intensity-Modulated Radiation Therapy
Drug: Irinotecan Hydrochloride
Drug: Leucovorin Calcium
Drug: Oxaliplatin

First Posted Date: 2013-07-12

Last Posted Date: 2023-12-05

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 23

Registration Number: NCT01897454

Locations: 🇺🇸
Montefiore Medical Center-Weiler Hospital, Bronx, New York, United States

Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Stage IIA Breast Cancer
Stage IIIC Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIB Breast Cancer
Stage IV Breast Cancer

Interventions: Drug: Cyclophosphamide
Other: Cytology Specimen Collection Procedure
Drug: Doxorubicin Hydrochloride
Other: Laboratory Biomarker Analysis
Drug: Paclitaxel
Biological: Trastuzumab

First Posted Date: 2013-07-12

Last Posted Date: 2023-07-14

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 132

Registration Number: NCT01897441

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy